The concept of decentralized clinical trials is not new. But the COVID crisis forced research operations leaders to accelerate their plans for remote and hybrid trials.
Decentralized clinical trials have now become one of the most important innovations in clinical research. But the meaning of the term “decentralized clinical trials” is still not universally understood.
What Are Decentralized Clinical Trials?
Decentralized clinical trials use technology to bring trials beyond the walls of academic medical centers and into doctors’ offices, pharmacies, and even patients’ homes.
In 2019, Scott Gottlieb, M.D., then-Commissioner of the FDA, stated, “We see great potential in using digital technologies to bring clinical trials to the patient, rather than always requiring the patient to travel to the investigator. This is an FDA priority.”
Here are five things you need to know about decentralized clinical trials: